Literature DB >> 23240160

Neisseria meningitidis, pathogenetic mechanisms to overcome the human immune defences.

R Gasparini1, D Amicizia, P L Lai, D Panatto.   

Abstract

Neisseria meningitidis is hosted only by humans and colonizes the nasopharynx; it survives in the human body by reaching an equilibrium with its exclusive host. Indeed, while cases of invasive disease are rare, the number of asymptomatic Neisseria meningitides carriers is far higher. The aim of this paper is to summarize the current knowledge of survival strategies of Neisseria meningitides against the human immune defences. Neisseria meningitidis possesses a variety of adaptive characteristics which enable it to avoid being killed by the immune system, such as the capsule, the lipopolysaccharide, groups of proteins that block the action of the antimicrobial proteins (AMP), proteins that inhibit the complement system, and components that prevent both the maturation and the perfect functioning of phagocytes. The main means of adhesion of Neisseria meningitides to the host cells are Pili, constituted by several proteins of whom the most important is Pilin E. Opacity-associated proteins (Opa) and (Opc) are two proteins that make an important contribution to the process of adhesion to the cell. Porins A and B contribute to neisserial adhesion and penetration into the cells, and also inhibit the complement system. Factor H binding protein (fhbp) binds factor H, allowing the bacteria to survive in the blood. Neisserial adhesin A (NadA) is a minor adhesin that is expressed by 50% of the pathogenic strains. NadA is known to be involved in cell adhesion and invasion and in the induction of proinflammatory cytokines. Neisserial heparin binding antigen (NHBA) binds heparin, thus increasing the resistance of the bacterium in the serum.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23240160

Source DB:  PubMed          Journal:  J Prev Med Hyg        ISSN: 1121-2233


  10 in total

1.  Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Authors:  Roberto Gasparini; Maurizio Comanducci; Daniela Amicizia; Filippo Ansaldi; Paola Canepa; Andrea Orsi; Giancarlo Icardi; Emanuela Rizzitelli; Gabriella De Angelis; Stefania Bambini; Monica Moschioni; Sara Comandi; Isabella Simmini; Giueseppe Boccadifuoco; Brunella Brunelli; Marzia Monica Giuliani; Mariagrazia Pizza; Donatella Panatto
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

Review 2.  Meningococcal B vaccination: real-world experience and future perspectives.

Authors:  Parvanè Kuhdari; Armando Stefanati; Silvia Lupi; Nicoletta Valente; Giovanni Gabutti
Journal:  Pathog Glob Health       Date:  2016-06-16       Impact factor: 2.894

3.  Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines.

Authors:  Eduardo Rojas; Johanna Hoyos; Neil J Oldfield; Philip Lee; Mike Flint; C Hal Jones; Dlawer A A Ala'Aldeen; Kathrin U Jansen; Annaliesa S Anderson
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 4.  How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.

Authors:  R Gasparini; D Panatto; N L Bragazzi; P L Lai; A Bechini; M Levi; P Durando; D Amicizia
Journal:  J Immunol Res       Date:  2015-08-17       Impact factor: 4.818

5.  Metaphylogenomic and potential functionality of the limpet Patella pellucida's gastrointestinal tract microbiome.

Authors:  Magda Dudek; Jessica Adams; Martin Swain; Matthew Hegarty; Sharon Huws; Joe Gallagher
Journal:  Int J Mol Sci       Date:  2014-10-20       Impact factor: 5.923

Review 6.  Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage.

Authors:  G Gabutti; A Stefanati; P Kuhdari
Journal:  J Prev Med Hyg       Date:  2015-08-31

Review 7.  Meningococcal B vaccination strategies and their practical application in Italy.

Authors:  R Gasparini; D Amicizia; P L Lai; D Panatto
Journal:  J Prev Med Hyg       Date:  2015-08-31

8.  Characterization of Oropharyngeal Carriage Isolates of Neisseria meningitidis in Healthy Korean Adolescents in 2015.

Authors:  Han Wool Kim; Soyoung Lee; Daeho Kwon; Jihei Cha; Jong Gyun Ahn; Kyung Hyo Kim
Journal:  J Korean Med Sci       Date:  2017-07       Impact factor: 2.153

9.  Fatal case of co-infection with dengue virus and Neisseria meningitidis during a dengue epidemic in the state of Rio de Janeiro, Brazil.

Authors:  Ivano de Filippis; Priscila Conrado Guerra Nunes; Claudia Ferreira de Andrade; Bianca de Santis Gonçalves; Eliane Saraiva de Araújo; Itacirema de Oliveira Bezerra; Ivan Rocha Ferreira da Silva; Rita Maria Nogueira; Ana Maria Bispo de Filippis
Journal:  JMM Case Rep       Date:  2016-08-30

Review 10.  New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers.

Authors:  D Panatto; D Amicizia; P L Lai; M L Cristina; A Domnich; R Gasparini
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.